Financials in USD. Standardized financial statements.
A compact view of how Rosetta Genomics Ltd. turns revenue into operating income and net income.
| Metric | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $9.23M | $8.27M | $1.33M | $405,000 | $201,000 | $103,000 | $279,000 | $150,000 | $0 | $0 |
| Revenue Growth? | +11.7% | +523.1% | +227.7% | +101.5% | +95.1% | -63.1% | +86.0% | 0.0% | 0.0% | 0.0% |
| Cost of Revenue? | $7.44M | $6.27M | $1.31M | $709,000 | $258,000 | $324,000 | $628,000 | $339,000 | $0 | $0 |
| Gross Profit? | $1.79M | $2.00M | $17,000 | -$304,000 | -$57,000 | -$221,000 | -$349,000 | -$189,000 | $0 | $0 |
| Gross Margin? | +19.4% | +24.1% | +1.3% | -75.1% | -28.4% | -214.6% | -125.1% | -126.0% | 0.0% | 0.0% |
| Operating Expenses? | $17.46M | $17.72M | $14.27M | $13.04M | $8.21M | $8.56M | $13.57M | $14.61M | $14.07M | $11.04M |
| Operating Income? | -$15.66M | -$15.72M | -$14.25M | -$13.35M | -$8.27M | -$8.78M | -$13.91M | -$14.80M | -$14.07M | -$11.04M |
| EBITDA? | -$15.32M | -$16.53M | -$14.17M | -$12.87M | -$7.99M | -$6.91M | -$12.52M | -$14.45M | -$13.76M | -$10.87M |
| Income Before Tax | -$16.27M | -$17.33M | -$14.51M | -$13.17M | -$10.70M | -$7.39M | -$12.97M | $0 | -$8.62M | $0 |
| Income Tax Expense | -$34,000 | $19,000 | $15,000 | $0 | $0 | $0 | $0 | $0 | $23,000 | $0 |
| Net Income? | -$16.23M | -$17.34M | -$14.53M | -$12.90M | -$10.46M | -$8.83M | -$14.76M | -$16.50M | -$9.46M | -$14.66M |
| EPS? | $-9.31 | $-13.79 | $-15.51 | $-16.08 | $-28.20 | $-208.80 | $-626.40 | $-878.40 | $-568.80 | $-950.40 |
| Diluted EPS? | $-9.31 | $-13.79 | $-15.51 | $-16.08 | $-28.20 | $-208.80 | $-626.40 | $-878.40 | $-568.80 | $-950.40 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality